ecqm.dataelement

Unfractionated Heparin Administered

Description:

Clinical Focus: This value set identifies heparin formulations that could reasonably be used to treat venous thromboembolism as a continuous infusion.

Data Element Scope: The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion. Using the Quality Data Model, this particular element will map to the Medication category.

Inclusion Criteria: Injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.

Exclusion Criteria: Concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria

Subject constrained to the Unfractionated Heparin

QDM Datatype: MedicationAdministered

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

Used By:

• CMS108v7,
• CMS190v7

Included in Unions:

• IsInLowRiskforVtEorOnAnticoagulantUnion,
• LowRiskforVtEorAnticoagulantAdministeredUnion,
• Numerator1Union,
• Numerator2Union

QDM Attributes

Subject.Statement

Defined in Activity

DataType

Constrained in UnfractionatedHeparinAdministered

UnfractionatedHeparin

AuthorDatetime

The time the data element was entered into the clinical software. Note, some datatypes include both Relevant Time and Author dateTime attributes. The purpose is to accommodate Author dateTime if the actual start and stop times are not available when evaluating for feasibility, and also to allow specification of a time for Negation Rationale.

Route

Refers to the path by which the medication or substance should be taken into the body systems, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.